EMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Emerson Electric Co (EMR) is not a strong buy for a beginner investor with a long-term focus at this moment. While the company has a strong dividend history and steady financial growth, the lack of significant positive trading signals, mixed analyst ratings, and limited upside potential in the near term suggest holding off on immediate investment.
The technical indicators are neutral. The MACD is above 0 but contracting, RSI is neutral at 54.979, and moving averages are converging. The stock is trading near its pivot level of 138.058, with resistance at 144.765 and support at 131.352.
Emerson has increased its dividend for 69 consecutive years, appealing to income-seeking investors.
The company's transformation into an industrial automation leader is largely complete, positioning it well for the future.
Financials for Q1 2026 show steady growth in revenue (+4.10% YoY), net income (+3.59% YoY), and EPS (+4.90% YoY).
Mixed analyst ratings with recent price target downgrades from Barclays and Wells Fargo.
Concerns about potential earnings miss in fiscal Q2 due to 7% exposure to the Middle East.
Limited upside potential as highlighted by BMO Capital and Deutsche Bank analysts.
In Q1 2026, Emerson reported revenue growth of 4.10% YoY to $4.35 billion, net income growth of 3.59% YoY to $606 million, and EPS growth of 4.90% YoY to $1.07. Gross margin improved slightly to 48.46%, up 0.85% YoY.
Analyst sentiment is mixed. Recent upgrades include Jefferies raising the price target to $175 and upgrading to Buy, citing strong order momentum and margin improvement. However, Barclays and Wells Fargo downgraded price targets to $140 and $135, respectively, citing demand uncertainties and geopolitical risks.
